DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

7.97 -0.14 (-1.73%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SPPI $7.97 -1.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.08
Previous Close $8.11
Daily Range $7.94 - $8.14
52-Week Range $6.36 - $10.32
Market Cap $523.9M
P/E Ratio -6.49
Dividend (Yield) $0.00 (0.0%)
Volume 672,195
Average Daily Volume 932,549
Current FY EPS -$0.68





Spectrum Pharmaceuticals, Inc. (SPPI) Description

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options. Website:

News & Commentary Rss Feed

A Bad Day for Spectrum Pharmaceuticals' Good News

Spectrum gets a drug approved, and then the share price drops.

Spectrum Pharmaceuticals: A Long-Term Bet

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals

Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon

Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq - Analyst Blog

Why Spectrum Pharmaceuticals (SPPI) Stock Is Higher This Morning

Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance

Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.

See More SPPI News...

SPPI's Top Competitors

SPPI $7.97 (-1.73%)
Current stock: SPPI
JNJ $102.95 (-0.26%)
Current stock: JNJ
PFE $29.38 (-0.37%)
Current stock: PFE
RHHBY $36.56 (-0.19%)
Current stock: RHHBY